Results 181 to 190 of about 22,949 (256)

Bee pollen as functional food and environmental bioindicator: current evidence and future challenges

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Bee pollen (BP), a plant‐derived product collected by honey bees, is increasingly promoted as a functional food due to its content of proteins, essential amino acids, lipids, vitamins, minerals, and bioactive compounds such as polyphenols and flavonoids.
Luigi Parrotta, Stefano Del Duca
wiley   +1 more source

Startups Driving Artificial Intelligence Into Clinical Dermatology

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Artificial intelligence (AI) is rapidly transitioning from innovation to routine clinical application in dermatology. This review examines how AI‐enabled technologies are being developed and integrated across diverse clinical purposes and workflows.
Dominique Du Crest   +10 more
wiley   +1 more source

Shadow Learning and Knowledge Redistribution: How Workers Appropriate Generative AI Outside Formal Organisational Systems

open access: yesKnowledge and Process Management, EarlyView.
ABSTRACT Organisations are ceding visibility over how their employees develop knowledge. As generative AI tools become widely accessible, workers are steadily building capabilities and co‐producing knowledge through informal AI engagements that operate entirely outside sanctioned training systems.
Eduardo Carlos Dittmar, Martin Sposato
wiley   +1 more source

Collagen‐membrane‐covered matrix‐associated chondrocyte implantation improves safety over periosteum‐covered MACI for large knee cartilage defects: A real‐world data analysis in the registry study

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
Abstract Purpose This registry study aimed to evaluate the safety and effectiveness of collagen membrane‐covered matrix‐associated autologous chondrocyte implantation (cMACI) versus periosteum‐covered MACI (pMACI) for large knee cartilage defects (Outerbridge III–IV, ≥4 cm²) in the femorotibial and/or patellofemoral joints with a minimum 2‐year follow ...
Yuji Uchio   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy